Filing Details
- Accession Number:
- 0001179110-10-010647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-16 13:00:00
- Reporting Period:
- 2010-06-14
- Filing Date:
- 2010-06-16
- Accepted Time:
- 2010-06-16 19:01:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1302445 | L David Brinkley | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Head Of Business Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-06-14 | 33,516 | $8.53 | 68,754 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-14 | 33,516 | $15.65 | 35,238 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-15 | 33,516 | $8.53 | 68,754 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-15 | 33,516 | $15.45 | 35,238 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-14 | 33,516 | $0.00 | 33,516 | $8.53 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-15 | 33,516 | $0.00 | 33,516 | $8.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,516 | 2010-06-17 | No | 4 | M | Direct | |
0 | 2010-06-17 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $15.32 to $15.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $15.38 to $15.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Immediately exercisable.